These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 4419323

  • 1. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE.
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract] [Full Text] [Related]

  • 2. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE.
    Adv Biochem Psychopharmacol; 1974 Jul; 12(0):403-14. PubMed ID: 4371765
    [No Abstract] [Full Text] [Related]

  • 3. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I, Iversen SD.
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract] [Full Text] [Related]

  • 4. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
    Le Moal M, Stinus L, Simon H, Tassin JP, Thierry AM, Blanc G, Glowinski J, Cardo B.
    Adv Biochem Psychopharmacol; 1977 Oct; 16():237-45. PubMed ID: 883544
    [No Abstract] [Full Text] [Related]

  • 5. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ, György L.
    Acta Physiol Acad Sci Hung; 1981 Oct; 58(3):225-33. PubMed ID: 7348023
    [Abstract] [Full Text] [Related]

  • 6. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N, Vidal L, Alvarez P, Blanco L, Torres A, Rodríguez A, Macías R.
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [Abstract] [Full Text] [Related]

  • 7. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM, Vigouret JM, Loew DM.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jun; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract] [Full Text] [Related]

  • 8. The effects of dopaminergic denervation on Na+-K+ ATPase activity and 3H-ouabain binding in rat corpus striatum.
    Bjur RA, Westfall DP.
    Proc West Pharmacol Soc; 1984 Jun; 27():35-8. PubMed ID: 6093132
    [No Abstract] [Full Text] [Related]

  • 9. Effect of somatostatin and its fragments on turning behaviour induced by unilateral substantia nigra lesion in the rat.
    Vécsei L, Bollók I, Varga J, Penke B, Telegdy G.
    Acta Physiol Hung; 1984 Jun; 64(2):157-62. PubMed ID: 6149666
    [Abstract] [Full Text] [Related]

  • 10. Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].
    Jaton AL, Loew DM, Vigouret JM.
    Br J Pharmacol; 1977 Mar; 59(3):464P-465P. PubMed ID: 843708
    [No Abstract] [Full Text] [Related]

  • 11. Dopaminergic activity of some apomorphine analogs.
    Cheng HC, Long JP, Van Orden LS, Cannon JG, O'Donnell JP.
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):89-106. PubMed ID: 968179
    [Abstract] [Full Text] [Related]

  • 12. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P, Miller RJ, Sahakian B.
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract] [Full Text] [Related]

  • 13. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW, Roberts DC, Koob GF.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [Abstract] [Full Text] [Related]

  • 14. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions.
    Mehta A, Thermos K, Chesselet MF.
    Synapse; 2000 Sep 15; 37(4):298-307. PubMed ID: 10891867
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
    Liou HH, Chen RC, Chen TH, Tsai YF, Tsai MC.
    Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):37-43. PubMed ID: 11264021
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic effects of lergotrile: possible involvement of a metabolite.
    McDevitt JT, Setler PE.
    Neuropharmacology; 1980 Jun 01; 19(6):537-42. PubMed ID: 6105627
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P, Colpaert FC, Marien M.
    J Pharmacol Exp Ther; 1999 Feb 01; 288(2):798-804. PubMed ID: 9918591
    [Abstract] [Full Text] [Related]

  • 19. Behavioral effects of dopamine agonists increase with age.
    Smith RC, Leelavathi DE, Lauritzen AM.
    Commun Psychopharmacol; 1978 Feb 01; 2(1):39-43. PubMed ID: 566185
    [No Abstract] [Full Text] [Related]

  • 20. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 01; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.